AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Alan Chiang

Alan Chiang

Bristol-Myers Squibb Co. - New York / United States
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 4390368
-
person_outline Alan Chiang's MOST POPULAR ARTICLES
1-) A randomized, double‐blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density Journal of Bone and Mineral Research 30 (2), 216-224, 2015
2-) Single‐and multiple‐dose randomized studies of blosozumab, a monoclonal antibody against sclerostin, in healthy postmenopausal women Journal of Bone and Mineral Research 29 (4), 935-943, 2014
3-) Abemaciclib inhibits renal tubular secretion without changing glomerular filtration rate Clinical Pharmacology & Therapeutics 105 (5), 1187-1195, 2019
4-) Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment Bone 59, 139-147, 2014
5-) The effect of discontinuing treatment with blosozumab: follow‐up results of a phase 2 randomized clinical trial in postmenopausal women with low bone mineral density Journal of Bone and Mineral Research 30 (9), 1717-1725, 2015